Taken together, our results suggested that β2-GPI DNA vaccine/FK506 treatment could suppress β2-GPI-specific humoral (IgG anti-β2-GPI antibody) and T cell immune responses (Th1 and Th17) in APS mice. The gene discussed is APOH; the disease is autoimmune polyendocrinopathy.